POLR3G and neoplasm: Expression levels of POLR3G were strongly correlated with T classification (T1-2 vs. T3-4, P = 0.001; Fig. 2A), pathological stage (stage I-II vs. stage III-IV, P = 0.005; Fig. 2B), tumor status (tumor free vs. with tumor, P = 0.001; Fig. 2C), tumor subtype (papillary vs. non-papillary, P < 0.001; Fig. 2D), and race (P < 0.001; Fig. 2E).